Table 5.
Cumulative probability of mortality (unadjusted) over 23 years and age-adjusted hazard ratios for mortality by GGT decile (N=11,264), United States, 1988-2011
Mortality outcome GGT decile* | No. of deaths | Unadjusted cumulative mortality† | Age-adjusted |
||
---|---|---|---|---|---|
HR‡ | 95% CI | p-value | |||
All-cause | |||||
1-9 | 2,915 | 32.5 | 1.0 | ||
10 | 522 | 40.5 | 1.66 | 1.46 – 1.88 | <0.001 |
Cardiovascular disease | |||||
1-9 | 1,229 | 14.6 | 1.0 | ||
10 | 196 | 17.2 | 1.51 | 1.27 – 1.80 | <0.001 |
Cancer | |||||
1-9 | 743 | 9.4 | 1.0 | ||
10 | 135 | 13.9 | 1.54 | 1.12 – 2.11 | 0.008 |
Diabetes | |||||
1-9 | 336 | 4.3 | 1.0 | ||
10 | 84 | 9.1 | 2.75 | 2.08 – 3.63 | <0.001 |
Liver disease | |||||
1-9 | 40 | 0.55 | 1.0 | ||
10 | 40 | 3.5 | 10.75 | 5.26 – 21.96 | <0.001 |
GGT, gamma glutamyltransferase; HR, hazard ratio; CI, confidence interval.
N=9,804 in deciles 1-9 and 1,460 in decile 10. Cut-point was 58 IU/L for men and 40 IU/L for women.
Estimated using Kaplan-Meier analysis.
Estimated using Cox proportional hazards regression analysis.